Dermal fibrosis and cutaneous necrosis after recombinant interferon‐β1a injection in a multiple sclerosis patient
- 10 December 2004
- journal article
- case report
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 19 (1) , 112-113
- https://doi.org/10.1111/j.1468-3083.2004.01086.x
Abstract
The most commonly reported side-effects of recombinant interferon-β1a and 1b include local inflammatory injection site reactions, headache, fever, myalgia and a flu-like syndrome. In this case report, we describe the occurrence of cutaneous necrosis and dermal fibrosis following intramuscular interferon-β1a injections in a multiple sclerosis patient. © 2004 European Academy of Dermatology and VenereologyKeywords
This publication has 7 references indexed in Scilit:
- Managing side effects of interferon-beta in patients with relapsing-remitting multiple sclerosisClinical Therapeutics, 1997
- Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosisAnnals of Neurology, 1996
- Cutaneous ulcerations and pustular psoriasis flare caused by recombinant interferon beta injections in patients with multiple sclerosisJournal of the American Academy of Dermatology, 1996
- Severe Necrotizing Cutaneous Lesions Complicating Treatment with Interferon Beta-1bNew England Journal of Medicine, 1995
- Cutaneous necrosis caused by injection of α‐interferon in a patient with chronic myelogeneous leukemiaAmerican Journal of Hematology, 1993
- Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosisNeurology, 1993
- Cutaneous Local Necrosis Following Interferon InjectionsInternational Journal of Dermatology, 1991